Recent Articles

• 
  Global Business

  Dong-A Socio to Reabsorb Dong-A Pharm, Become Holding Company

  Exterior view of Dong-A Socio Holdings and Dong-A Pharmaceutical. Provided by Dong-A Socio Holdings Dong-A Socio Holdings will reabsorb Dong-A Pharmaceutical, which was carved out through a physical split during its transition to a holding company structure in 2013, after 13 years. The move is inten

  2026.07.23
• 
  Biopharma

  Samsung Biologics Q2 operating profit KRW 586.4 billion, up 23%

  Panoramic view of Samsung Biologics headquarters. Courtesy of Samsung Biologics Samsung Biologics continued its solid growth momentum, supported by stable business operations and favorable foreign exchange effects.Samsung Biologics announced on the 23rd that it posted sales of KRW 1,320.9 billion an

  2026.07.23
• 
  Medical / Research

  “Is Stomach Ulcer a Man’s Disease?” Women Over 80 at Higher Risk

  Peptic ulcer disease is a condition in which the mucosa of the stomach or duodenum is damaged and wounds form. In severe cases, it can lead to serious complications such as bleeding or perforation. Getty Images Bank There is a perception that “stomach ulcers are a man’s disease,” but this can change

  2026.07.22
• 
  MedTech

  KRICT Develops Near-Infrared Phosphor for Long Surgeries

  From right, KRICT’s Nam Sang-hwan principal researcher, Park Young-il principal researcher, and researcher Choi Min-seok. Provided by KRICT Korea Research Institute of Chemical Technology (KRICT) announced on the 21st that it has developed a next-generation near-infrared fluorophore capable of maint

  2026.07.22
• 
  AI Healthcare

  One-Minute Video Analysis Fills Specialist Shortage

  Staff members at the corporate research institute of MaiT in Seocho-gu, Seoul, on the 21st. Courtesy of MaiT There are not few cases in which children with congenital hip disorders miss the optimal timing for treatment because it is difficult to see a specialist. There are only about 10 pediatric or

  2026.07.22
• 
  Biopharma

  Celltrion Truxima Gains U.S. Share, Four Months No. 1

  Celltrion’s hematologic cancer treatment is consolidating its leading position in the United States, the world’s largest market.Celltrion announced on the 21st that “Truxima” (ingredient name: rituximab) has ranked No. 1 in market share in the United States for four consecutive months.According to d

  2026.07.21
• 
  Global Business

  Mussel-Inspired Hemostat Wins EU Patent, Targets Germany

  SCL Science’s surgical hemostatic agent “InnoSeal Plus DL” has received a decision for patent registration in Europe. The domestically developed surgical hemostatic agent “InnoSeal Plus DL” has received a decision for patent registration in Europe, paving the way for accelerated entry into the Europ

  2026.07.21
• 
  Bioprocessing / CDMO

  Samsung Biologics Targets KRW 281 Trillion Obesity Market

  The world’s largest contract development and manufacturing organization (CDMO) for biopharmaceuticals, Samsung Biologics, is set to acquire Swiss peptide‑specialized CDMO company PolyPeptide Group for approximately KRW 2.7 trillion, the largest merger and acquisition (M&A) deal in the history of the

  2026.07.21
• 
  Aesthetic

  Drugmakers Enter KRW 2 Trillion Anti-Wrinkle Market

  Getty Image Bank Cosmetics that highlight pharmaceutical and bio technologies, such as those using “salmon DNA” as an ingredient for research on cellular aging, are being launched one after another. As demand for high-functionality cosmetics grows among the “Young Old” generation—older consumers who

  2026.07.20
• 
  AI Healthcare

  Daewoong Pharma Deploys ‘Think’ AI Blood Pressure System at Samsung Hospital

  Daewoong Pharmaceutical has introduced an artificial intelligence (AI)-based bedside monitoring system, “thynC,” with an added blood pressure monitoring function at Samsung Medical Center and has begun pilot operation. On the 20th, Daewoong Pharmaceutical announced that, together with domestic healt

  2026.07.20